NCRI 2017 | Heating up a tumor: modulating the immunoscore

The immunoscore is a predictive tool that looks at a cancer patient’s adaptive immunity to predict survival and recurrence, amongst other uses. In this interview, Jerome Galon, PhD, of Cordeliers Research Center, Paris, France, gives an overview of how a low immunoscore, indicating a ‘cold’ tumor with few immune cells in it, can be changed through treatments such as immunotherapy or anti-EGFR therapies to stimulate immune activity inside the tumor, and increase the patient’s immunoscore. This video was recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.